ASP7317 Clinical Trials (2026): 1 Studies for Age-Related Macular Degeneration
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ASP7317 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Age-Related Macular Degeneration) and 42 total planned enrollment. 1 ASP7317 clinical trial is actively recruiting at 12 U.S. sites across 10 states. Most recent activity: NCT03178149 (Jun 2026).
Where to Participate: All ASP7317 Trial Sites in the U.S. (12 sites across 10 states)
Every actively recruiting ASP7317trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Jules Stein Eye Institute | Los Angeles90095 | NCT03178149 | Map |
| CA | Stanford University Byers Eye Institute | Palo Alto94303 | NCT03178149 | Map |
| CA | Kaiser Permanente Riverside Medical Center | Riverside92505 | NCT03178149 | Map |
| FL | Retina Specialty Institute | Pensacola35203 | NCT03178149 | Map |
| GA | Emory University Eye Center | Atlanta30322 | NCT03178149 | Map |
| IL | University Retina and Macula Associates | Oak Forest60452 | NCT03178149 | Map |
| MA | Ophthalmic Consultants of Boston | Boston02114 | NCT03178149 | Map |
| MI | University of Michigan Kellog Eye Center | Ann Arbor48105 | NCT03178149 | Map |
| MS | Deep Blue Retina | Southaven38671 | NCT03178149 | Map |
| PA | Mid-Atlantic Retina | Philadelphia19107 | NCT03178149 | Map |
| TX | Retina Foundation of the Southwest | Dallas75231 | NCT03178149 | Map |
| WA | Spokane Eye Clinical Research | Spokane99204 | NCT03178149 | Map |
ASP7317 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting ASP7317 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT03178149 | A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration | P1 | Age-Related Macular Degeneration | 42 | Jul 2018 |
All ASP7317 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT03178149 | A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration | P1 | recruiting | 42 | Astellas Institute for Regenerative Medicine | Jul 2018 |
ASP7317 clinical trials: frequently asked questions
- How many ASP7317 clinical trials are there?
- 1 ASP7317 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are ASP7317 clinical trials recruiting in 2026?
- Yes — 1 ASP7317 trial is actively recruiting in 2026, with 12 U.S. sites across 10 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is ASP7317 being studied for?
- ASP7317 is being studied for Age-Related Macular Degeneration. The trials are grouped by indication on this page.
- What phase is ASP7317 in?
- ASP7317 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ASP7317 clinical trials?
- The lead sponsor across the most ASP7317 trials is Astellas Institute for Regenerative Medicine. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ASP7317as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: